FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034647529> ?p ?o ?g. }

• W2034647529 endingPage "42" @default.
• W2034647529 startingPage "37" @default.
• W2034647529 abstract "It is almost 60 years since Prof. Alfred Jost reported the seminal observations regarding Müllerian inhibiting substance (MIS). His experiments clearly showed that a testicular product other than testosterone, a Müllerian inhibitor, was responsible for Müllerian duct regression. Twenty-five years later Dr. Picon established an organ culture assay which paved the way for the initial studies into the biochemistry and biology of Müllerian inhibiting substance, also known as Anti-Müllerian hormone (AMH), undertaken first in Dr. Nathalie Josso's Laboratory in Paris then in our own laboratory in Boston. Purification of MIS led to cloning the human gene and production of recombinant human (rhMIS). MIS is a 140 kDa glycoprotein homodimer which is activated by a biosynthetic protease, cleaving MIS into an aminoterminus (110 kDa) and a carboxyterminus (25 kDa). The latter domain is sufficient for biological activities. MIS functions by interacting with two receptors; a type II binds the hormone and at type I that initiates downstream signaling. The MIS type II receptor has been cloned and functionally confirmed as distinct from that of other members of the TGFbeta superfamily. MIS can employ a number of type I receptors (ALK2, ALK3, ALK6) and BMP receptor specific SMADS 1, 5, and 8 in various tissue specific contexts. Cell lines derived from human ovarian, breast, and prostate tumors, and from rodent Leydig cell tumors, which respond to MIS in growth inhibition assays, all express the MIS type II receptor. A variety of signal transduction pathways are associated with the grown inhibition mediated by MIS. For example, breast and prostate cancer cell lines use a MIS-mediated NFkappaB pathway leading to G1 arrest and apoptosis. The ovarian cancer cell lines employ a pathway which enhances p16, modulates the E2Fs, and induces apoptosis. These signal transduction events can establish new rational treatment strategies to complement the growth inhibitory effects mediated by MIS. These combination strategies are being tested in vitro, and where appropriate will be tested in vivo using the highly purified MIS preparations, prior to use in early human clinical trials." @default.
• W2034647529 created "2016-06-24" @default.
• W2034647529 creator A5015776672 @default.
• W2034647529 creator A5016231600 @default.
• W2034647529 creator A5025547698 @default.
• W2034647529 creator A5053327218 @default.
• W2034647529 creator A5069961391 @default.
• W2034647529 date "2003-12-01" @default.
• W2034647529 modified "2023-09-28" @default.
• W2034647529 title "Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications" @default.
• W2034647529 cites W1481497040 @default.
• W2034647529 cites W1990593546 @default.
• W2034647529 cites W2000146657 @default.
• W2034647529 cites W2003287339 @default.
• W2034647529 cites W2009669398 @default.
• W2034647529 cites W2010931869 @default.
• W2034647529 cites W2015552576 @default.
• W2034647529 cites W2018952758 @default.
• W2034647529 cites W2031271949 @default.
• W2034647529 cites W2037673347 @default.
• W2034647529 cites W2063586478 @default.
• W2034647529 cites W2080786870 @default.
• W2034647529 cites W2086484290 @default.
• W2034647529 cites W2089928608 @default.
• W2034647529 cites W2110761705 @default.
• W2034647529 cites W2116112998 @default.
• W2034647529 cites W2120842955 @default.
• W2034647529 cites W2132019814 @default.
• W2034647529 cites W2163514784 @default.
• W2034647529 cites W2166037649 @default.
• W2034647529 cites W2335974496 @default.
• W2034647529 cites W4235586590 @default.
• W2034647529 cites W4242486335 @default.
• W2034647529 cites W4247208370 @default.
• W2034647529 cites W4248809276 @default.
• W2034647529 cites W4250240558 @default.
• W2034647529 cites W4254089460 @default.
• W2034647529 cites W4256017905 @default.
• W2034647529 doi "https://doi.org/10.1016/j.mce.2003.09.009" @default.
• W2034647529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14656474" @default.
• W2034647529 hasPublicationYear "2003" @default.
• W2034647529 type Work @default.
• W2034647529 sameAs 2034647529 @default.
• W2034647529 citedByCount "31" @default.
• W2034647529 countsByYear W20346475292013 @default.
• W2034647529 countsByYear W20346475292014 @default.
• W2034647529 countsByYear W20346475292018 @default.
• W2034647529 countsByYear W20346475292019 @default.
• W2034647529 countsByYear W20346475292020 @default.
• W2034647529 countsByYear W20346475292021 @default.
• W2034647529 crossrefType "journal-article" @default.
• W2034647529 hasAuthorship W2034647529A5015776672 @default.
• W2034647529 hasAuthorship W2034647529A5016231600 @default.
• W2034647529 hasAuthorship W2034647529A5025547698 @default.
• W2034647529 hasAuthorship W2034647529A5053327218 @default.
• W2034647529 hasAuthorship W2034647529A5069961391 @default.
• W2034647529 hasConcept C126322002 @default.
• W2034647529 hasConcept C134018914 @default.
• W2034647529 hasConcept C170493617 @default.
• W2034647529 hasConcept C2778780466 @default.
• W2034647529 hasConcept C54355233 @default.
• W2034647529 hasConcept C62478195 @default.
• W2034647529 hasConcept C71315377 @default.
• W2034647529 hasConcept C71924100 @default.
• W2034647529 hasConcept C86803240 @default.
• W2034647529 hasConcept C95444343 @default.
• W2034647529 hasConceptScore W2034647529C126322002 @default.
• W2034647529 hasConceptScore W2034647529C134018914 @default.
• W2034647529 hasConceptScore W2034647529C170493617 @default.
• W2034647529 hasConceptScore W2034647529C2778780466 @default.
• W2034647529 hasConceptScore W2034647529C54355233 @default.
• W2034647529 hasConceptScore W2034647529C62478195 @default.
• W2034647529 hasConceptScore W2034647529C71315377 @default.
• W2034647529 hasConceptScore W2034647529C71924100 @default.
• W2034647529 hasConceptScore W2034647529C86803240 @default.
• W2034647529 hasConceptScore W2034647529C95444343 @default.
• W2034647529 hasIssue "1-2" @default.
• W2034647529 hasLocation W20346475291 @default.
• W2034647529 hasLocation W20346475292 @default.
• W2034647529 hasOpenAccess W2034647529 @default.
• W2034647529 hasPrimaryLocation W20346475291 @default.
• W2034647529 hasRelatedWork W1996846474 @default.
• W2034647529 hasRelatedWork W2018368842 @default.
• W2034647529 hasRelatedWork W2033472167 @default.
• W2034647529 hasRelatedWork W2034583712 @default.
• W2034647529 hasRelatedWork W2052453588 @default.
• W2034647529 hasRelatedWork W2061429094 @default.
• W2034647529 hasRelatedWork W2063619316 @default.
• W2034647529 hasRelatedWork W2126532023 @default.
• W2034647529 hasRelatedWork W2169225653 @default.
• W2034647529 hasRelatedWork W2414846389 @default.
• W2034647529 hasVolume "211" @default.
• W2034647529 isParatext "false" @default.
• W2034647529 isRetracted "false" @default.
• W2034647529 magId "2034647529" @default.
• W2034647529 workType "article" @default.